Publications

Export 76 results:
Sort by: Author [ Title (Desc)] Type Year
Filters: First Letter Of Title is G  [Clear All Filters]
A B C D E F [G] H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
G
Drake AJ, van den Driesche S, Scott HM, Hutchison GR, Seckl JR, Sharpe RM. Glucocorticoids amplify dibutyl phthalate-induced disruption of testosterone production and male reproductive development. Endocrinology. 2009;150(11):5055-64. Abstract
Logie JJ, Ali S, Marshall KM, Heck MM, Walker BR, Hadoke PW. Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration. PLoS ONE. 2010;5(12):e14476. Abstract
Feldmer M, Kaling M, Takahashi S, Mullins JJ, Ganten D. Glucocorticoid- and estrogen-responsive elements in the 5’-flanking region of the rat angiotensinogen gene. Journal of hypertension. 1991;9:1005-12. Abstract
Reynolds RM, Labad J, Sears AV, Williamson RM, Strachan MW, Deary IJ, et al. Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study. Eur J Endocrinol. 2012;166(5):861-8. Abstract
Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP, et al. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta. Mol Endocrinol. 2008;22(9):2049-60. Abstract
Panarelli M, Holloway CD, Fraser R, Connell JM, Ingram MC, Anderson NH, et al. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. The Journal of clinical endocrinology and metabolism. 1998;83:1846-52. Abstract
Kenyon CJ, Panarelli M, Zagato L, Torielli L, Heeley RP, Holloway CD, et al. Glucocorticoid receptor polymorphism in genetic hypertension. Journal of molecular endocrinology. 1998;21:41-50. Abstract
Michailidou Z, Carter RN, Marshall E, Sutherland HG, Brownstein DG, Owen E, et al. Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2008;22:3896-907. Abstract
Seckl JR, Meaney MJ. Glucocorticoid programming. Annals of the New York Academy of Sciences. 2004;1032:63-84. Abstract
Seckl JR. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Molecular and cellular endocrinology. 2001;185:61-71. Abstract
O’Regan D, Welberg LL, Holmes MC, Seckl JR. Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences. Seminars in neonatology : SN. 2001;6:319-29. Abstract
Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, Morton NM, et al. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clinical endocrinology. 2006;65:81-7. Abstract
Andrew R, Gale CR, Walker BR, Seckl JR, Martyn CN. Glucocorticoid metabolism and the Metabolic Syndrome: associations in an elderly cohort. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 2002;110:284-90. Abstract
Andrew R, Forsberg H, Cederquist K, Walker BR, Olsson T. Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy. The Journal of clinical endocrinology and metabolism. 2001;86:4276-83. Abstract
Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993;341:339-41. Abstract
O’Regan D, Kenyon CJ, Seckl JR, Holmes MC. Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. American journal of physiology. Endocrinology and metabolism. 2004;287:E863-70. Abstract
Freeman AI, Munn HL, Lyons V, Dammermann A, Seckl JR, Chapman KE. Glucocorticoid down-regulation of rat glucocorticoid receptor does not involve differential promoter regulation. The Journal of endocrinology. 2004;183:365-74. Abstract
Seckl JR, Meaney MJ. Glucocorticoid "programming" and PTSD risk. Annals of the New York Academy of Sciences. 2006;1071:351-78. Abstract
Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA. The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE. Heart. 2010;96(14):1095-101. Abstract
Yamaguchi S, Bell HS, Shinoda J, Holmes MC, Wharton SB, Whittle IR. Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model. British journal of neurosurgery. 2002;16:567-72. Abstract
Beaumont NJ, Skinner VO, Tan TM, Ramesh BS, Byrne DJ, MacColl GS, et al. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. The Journal of biological chemistry. 2003;278:8877-80. Abstract
Smith JW, Seckl JR, Evans AT, Costall B, Smythe JW. Gestational stress induces post-partum depression-like behaviour and alters maternal care in rats. Psychoneuroendocrinology. 2004;29:227-44. Abstract
Sharp MG, Kantachuvesiri S, Mullins JJ. Genotype and cardiovascular phenotype: lessons from genetically manipulated animals and diseased humans. Current opinion in nephrology and hypertension. 1997;6:51-7. Abstract
Lauc G, Essafi A, Huffman JE, Hayward C, Knežević A, Kattla JJ, et al. Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation. PLoS Genet. 2010;6(12):e1001256. Abstract
Kirin M, McQuillan R, Franklin CS, Campbell H, McKeigue PM, Wilson JF. Genomic runs of homozygosity record population history and consanguinity. PLoS ONE. 2010;5(11):e13996. Abstract